Display Settings:

Format

Send to:

Choose Destination
Clin Geriatr Med. 2006 Feb;22(1):17-32, vii-viii.

Warfarin pharmacology, clinical management, and evaluation of hemorrhagic risk for the elderly.

Author information

  • Division of Geriatrics, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA. lajacobs@montefiore.org

Abstract

Elderly patients as a group may present more of a challenge in managing warfarin therapy because of alterations in pharmacokinetics from other medications, diet, and disease; pharmacodynamic changes; increased risk for hemorrhage; and difficulty in monitoring. The elderly, however, may derive the most benefit from warfarin therapy for certain indications, such as the prevention of stroke in atrial fibrillation or recurrent events following deep venous thrombosis. Warfarin can be managed as effectively as in other populations with careful attention to these issues.

PMID:
16377465
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk